Cartesian Therapeutics In...
18.50
0.48 (2.66%)
At close: Jan 15, 2025, 1:41 PM

Cartesian Therapeutics Inc. Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for RNAC stock have an median target of 41.5, with a low estimate of 39 and a high estimate of 45. The median target predicts an increase of 124.32% from the current stock price of 18.50.

Analyst Consensus: Buy
Target Low Average Median High
Price $39 $41.67 $41.5 $45
Change 110.81% 125.24% 124.32% 143.24%

AI Analyst Report

Needham has reaffirmed a Buy rating on Cartesian T... Unlock content with Pro Subscription

Updated Jan 13, 2025

Rating Aug 24Sep 24Oct 24Nov 24Dec 24Jan 25
Strong Buy 000010
Buy 321321
Hold 000000
Sell 000000
Strong Sell 000000
Total 3 2 1 3 3 1

Financial Forecast this Year

Revenue This Year
39.74M
from 26.00M
Increased by 52.8%
Revenue Next Year
6.29M
from 39.74M
Increased by -84.2%
EPS This Year
-5.99
from -42.49
Increased by 85.9%
EPS Next Year
-3.46
from -5.99
Increased by 42.2%